208 related articles for article (PubMed ID: 12145772)
1. Troglitazone improves blood flow by inhibiting neointimal formation after balloon injury in Otsuka Long-Evans Tokushima fatty rats.
Min KM; Park SW; Cho KY; Song MS; Kim DK; Park GS; Lee MK
Metabolism; 2002 Aug; 51(8):998-1002. PubMed ID: 12145772
[TBL] [Abstract][Full Text] [Related]
2. Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia.
Law RE; Meehan WP; Xi XP; Graf K; Wuthrich DA; Coats W; Faxon D; Hsueh WA
J Clin Invest; 1996 Oct; 98(8):1897-905. PubMed ID: 8878442
[TBL] [Abstract][Full Text] [Related]
3. Troglitazone suppresses intimal formation following balloon injury in insulin-resistant Zucker fatty rats.
Shinohara E; Kihara S; Ouchi N; Funahashi T; Nakamura T; Yamashita S; Kameda-Takemura K; Matsuzawa Y
Atherosclerosis; 1998 Feb; 136(2):275-9. PubMed ID: 9543098
[TBL] [Abstract][Full Text] [Related]
4. Troglitazone and metformin, but not glibenclamide, decrease blood pressure in Otsuka Long Evans Tokushima Fatty rats.
Kosegawa I; Chen S; Awata T; Negishi K; Katayama S
Clin Exp Hypertens; 1999 Apr; 21(3):199-211. PubMed ID: 10225476
[TBL] [Abstract][Full Text] [Related]
5. Troglitazone improves GLUT4 expression in adipose tissue in an animal model of obese type 2 diabetes mellitus.
Furuta M; Yano Y; Gabazza EC; Araki-Sasaki R; Tanaka T; Katsuki A; Hori Y; Nakatani K; Sumida Y; Adachi Y
Diabetes Res Clin Pract; 2002 Jun; 56(3):159-71. PubMed ID: 11947963
[TBL] [Abstract][Full Text] [Related]
6. Troglitazone ameliorates abnormal activity of protein tyrosine phosphatase in adipose tissues of Otsuka Long-Evans Tokushima Fatty rats.
Tagami S; Honda T; Yoshimura H; Homma H; Ohno K; Ide H; Sakaue S; Kawakami Y
Tohoku J Exp Med; 2002 Jul; 197(3):169-81. PubMed ID: 12365558
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of action of troglitazone in the prevention of high glucose-induced migration and proliferation of cultured coronary smooth muscle cells.
Yasunari K; Kohno M; Kano H; Yokokawa K; Minami M; Yoshikawa J
Circ Res; 1997 Dec; 81(6):953-62. PubMed ID: 9400375
[TBL] [Abstract][Full Text] [Related]
8. Effects of troglitazone on collagen accumulation and distensibility of aortic wall in prestage of non-insulin-dependent diabetes mellitus of Otsuka Long-Evans Tokushima Fatty rats.
Mizushige K; Noma T; Yao L; Yu Y; Kiyomoto H; Hosomi N; Fukui T; Kimura S; Abe Y; Matsuo H
J Cardiovasc Pharmacol; 2000 Jan; 35(1):150-5. PubMed ID: 10630746
[TBL] [Abstract][Full Text] [Related]
9. Troglitazone prevents fatty changes of the liver in obese diabetic rats.
Jia DM; Tabaru A; Akiyama T; Abe S; Otsuki M
J Gastroenterol Hepatol; 2000 Oct; 15(10):1183-91. PubMed ID: 11106100
[TBL] [Abstract][Full Text] [Related]
10. Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome.
Azziz R; Ehrmann DA; Legro RS; Fereshetian AG; O'Keefe M; Ghazzi MN;
Fertil Steril; 2003 Apr; 79(4):932-7. PubMed ID: 12749433
[TBL] [Abstract][Full Text] [Related]
11. Troglitazone improves endothelial function and augments renal klotho mRNA expression in Otsuka Long-Evans Tokushima Fatty (OLETF) rats with multiple atherogenic risk factors.
Yamagishi T; Saito Y; Nakamura T; Takeda S; Kanai H; Sumino H; Kuro-o M; Nabeshima Y; Kurabayashi M; Nagai R
Hypertens Res; 2001 Nov; 24(6):705-9. PubMed ID: 11768731
[TBL] [Abstract][Full Text] [Related]
12. Effects of fructose and troglitazone on phospholipid fatty acid composition in rat skeletal muscle.
Clore JN; Li L; Rizzo WB
Lipids; 2000 Nov; 35(11):1281-7. PubMed ID: 11132187
[TBL] [Abstract][Full Text] [Related]
13. Troglitazone stimulates pancreatic growth in congenitally CCK-A receptor-deficient OLETF rats.
Jia DM; Fukumitsu KI; Tabaru A; Akiyama T; Otsuki M
Am J Physiol Regul Integr Comp Physiol; 2001 May; 280(5):R1332-40. PubMed ID: 11294751
[TBL] [Abstract][Full Text] [Related]
14. Troglitazone inhibits growth and improves insulin signaling by suppression of angiotensin II action in vascular smooth muscle cells from spontaneously hypertensive rats.
Fukuda N; Hu WY; Teng J; Chikara S; Nakayama M; Kishioka H; Kanmatsuse K
Atherosclerosis; 2002 Aug; 163(2):229-39. PubMed ID: 12052469
[TBL] [Abstract][Full Text] [Related]
15. Troglitazone inhibits the expression of inducible nitric oxide synthase in adipocytes in vitro and in vivo study in 3T3-L1 cells and Otsuka Long-Evans Tokushima Fatty rats.
Dobashi K; Asayama K; Nakane T; Kodera K; Hayashibe H; Nakazawa S
Life Sci; 2000 Sep; 67(17):2093-101. PubMed ID: 11057759
[TBL] [Abstract][Full Text] [Related]
16. Troglitazone reduces contraction by inhibition of vascular smooth muscle cell Ca2+ currents and not endothelial nitric oxide production.
Song J; Walsh MF; Igwe R; Ram JL; Barazi M; Dominguez LJ; Sowers JR
Diabetes; 1997 Apr; 46(4):659-64. PubMed ID: 9075808
[TBL] [Abstract][Full Text] [Related]
17. Troglitazone prevents hyperglycemia-induced but not glucosamine-induced insulin resistance.
Miles PD; Higo K; Romeo OM; Lee MK; Rafaat K; Olefsky JM
Diabetes; 1998 Mar; 47(3):395-400. PubMed ID: 9519745
[TBL] [Abstract][Full Text] [Related]
18. Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome.
Paradisi G; Steinberg HO; Shepard MK; Hook G; Baron AD
J Clin Endocrinol Metab; 2003 Feb; 88(2):576-80. PubMed ID: 12574183
[TBL] [Abstract][Full Text] [Related]
19. Effects of troglitazone on cellular differentiation, insulin signaling, and glucose metabolism in cultured human skeletal muscle cells.
Kausch C; Krützfeldt J; Witke A; Rettig A; Bachmann O; Rett K; Matthaei S; Machicao F; Häring HU; Stumvoll M
Biochem Biophys Res Commun; 2001 Jan; 280(3):664-74. PubMed ID: 11162573
[TBL] [Abstract][Full Text] [Related]
20. Dietary troglitazone decreases oxidative stress in early stage type II diabetic rats.
Fukui T; Noma T; Mizushige K; Aki Y; Kimura S; Abe Y
Life Sci; 2000 Apr; 66(21):2043-9. PubMed ID: 10823344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
